Bella Mehta1, Kaylee Ho2, Vicki Ling3, Susan Goodman1, Michael Parks1, Bheeshma Ravi3,4, Samprit Banerjee5, Fei Wang6, Said Ibrahim6, Peter Cram3,7. 1. Department of Medicine, Hospital for Special Surgery, New York, NY, USA. 2. Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY, USA. 3. ICES, Toronto, Ontario, Canada. 4. Sunnybrook Health Sciences Centre, Holland Centre, Toronto, Ontario, USA. 5. Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. 6. Department of Medicine, Weill Cornell Medicine, New York, NY, USA. 7. Department of Medicine, University of Texas Medical Branch, Galveston, TX, USA.
Abstract
BACKGROUND: Income-based differences in the use of and outcomes in TKA have been studied; however, it is not known if different healthcare systems affect this relationship. Although Canada's single-payer healthcare system is assumed to attenuate the wealth-based differences in TKA use observed in the United States, empirical cross-border comparisons are lacking. QUESTIONS/PURPOSES: (1) Does TKA use differ between Pennsylvania, USA, and Ontario, Canada? (2) Are income-based disparities in TKA use larger in Pennsylvania or Ontario? (3) Are TKA outcomes (90-day mortality, 90-day readmission, and 1-year revision rates) different between Pennsylvania and Ontario? (4) Are income-based disparities in TKA outcomes larger in Pennsylvania or Ontario? METHODS: We identified all patients hospitalized for primary TKA in this cross-border retrospective analysis, using administrative data for 2012 to 2018, and we found a total of 161,244 primary TKAs in Ontario and 208,016 TKAs in Pennsylvania. We used data from the Pennsylvania Health Care Cost Containment Council, Harrisburg, PA, USA, and the ICES (formally the Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada. We linked patient-level data to the respective census data to determine community-level income using ZIP Code or postal code of residence and stratified patients into neighborhood income quintiles. We compared TKA use (age and gender, standardized per 10,000 population per year) for patients residing in the highest-income versus the lowest-income quintile neighborhoods. Similarly secondary outcomes 90-day mortality, 90-day readmission, and 1-year revision rates were compared between the two regions and analyzed by income groups. RESULTS: TKA use was higher in Pennsylvania than in Ontario overall and for all income quintiles (lowest income quartile: 31 versus 18 procedures per 10,000 population per year; p < 0.001; highest income quartile: 38 versus 23 procedures per 10,000 population per year; p < 0.001). The relative difference in use between the highest-income and lowest-income quintile was larger in Ontario (28% higher) than in Pennsylvania (23% higher); p < 0.001. Patients receiving TKA in Pennsylvania were more likely to be readmitted within 90 days and were more likely to undergo revision within the first year than patients in Ontario, but there was no difference in mortality at 1 year. When comparing income groups, there were no differences between the countries in 90-day mortality, readmission, or 1-year revision rates (p > 0.05). CONCLUSION: These results suggest that universal health insurance through a single-payer may not reduce the income-based differences in TKA access that are known to exist in the United States. Future studies are needed determine if our results are consistent across other geographic regions and other surgical procedures. LEVEL OF EVIDENCE: Level III, therapeutic study.
BACKGROUND: Income-based differences in the use of and outcomes in TKA have been studied; however, it is not known if different healthcare systems affect this relationship. Although Canada's single-payer healthcare system is assumed to attenuate the wealth-based differences in TKA use observed in the United States, empirical cross-border comparisons are lacking. QUESTIONS/PURPOSES: (1) Does TKA use differ between Pennsylvania, USA, and Ontario, Canada? (2) Are income-based disparities in TKA use larger in Pennsylvania or Ontario? (3) Are TKA outcomes (90-day mortality, 90-day readmission, and 1-year revision rates) different between Pennsylvania and Ontario? (4) Are income-based disparities in TKA outcomes larger in Pennsylvania or Ontario? METHODS: We identified all patients hospitalized for primary TKA in this cross-border retrospective analysis, using administrative data for 2012 to 2018, and we found a total of 161,244 primary TKAs in Ontario and 208,016 TKAs in Pennsylvania. We used data from the Pennsylvania Health Care Cost Containment Council, Harrisburg, PA, USA, and the ICES (formally the Institute for Clinical Evaluative Sciences), Toronto, Ontario, Canada. We linked patient-level data to the respective census data to determine community-level income using ZIP Code or postal code of residence and stratified patients into neighborhood income quintiles. We compared TKA use (age and gender, standardized per 10,000 population per year) for patients residing in the highest-income versus the lowest-income quintile neighborhoods. Similarly secondary outcomes 90-day mortality, 90-day readmission, and 1-year revision rates were compared between the two regions and analyzed by income groups. RESULTS: TKA use was higher in Pennsylvania than in Ontario overall and for all income quintiles (lowest income quartile: 31 versus 18 procedures per 10,000 population per year; p < 0.001; highest income quartile: 38 versus 23 procedures per 10,000 population per year; p < 0.001). The relative difference in use between the highest-income and lowest-income quintile was larger in Ontario (28% higher) than in Pennsylvania (23% higher); p < 0.001. Patients receiving TKA in Pennsylvania were more likely to be readmitted within 90 days and were more likely to undergo revision within the first year than patients in Ontario, but there was no difference in mortality at 1 year. When comparing income groups, there were no differences between the countries in 90-day mortality, readmission, or 1-year revision rates (p > 0.05). CONCLUSION: These results suggest that universal health insurance through a single-payer may not reduce the income-based differences in TKA access that are known to exist in the United States. Future studies are needed determine if our results are consistent across other geographic regions and other surgical procedures. LEVEL OF EVIDENCE: Level III, therapeutic study.
Authors: Maria J Small; Andra H James; Trace Kershaw; Betty Thames; Ravi Gunatilake; Haywood Brown Journal: Obstet Gynecol Date: 2012-02 Impact factor: 7.661
Authors: Jarvis T Chen; David H Rehkopf; Pamela D Waterman; S V Subramanian; Brent A Coull; Bruce Cohen; Mary Ostrem; Nancy Krieger Journal: J Urban Health Date: 2006-11 Impact factor: 3.671
Authors: Kevin M Gorey; Isaac N Luginaah; Emma Bartfay; GuangYong Zou; Sundus Haji-Jama; Eric J Holowaty; Caroline Hamm; Sindu M Kanjeekal; Frances C Wright; Madhan K Balagurusamy; Nancy L Richter Journal: Health Soc Work Date: 2013-11
Authors: Nera Agabiti; Sally Picciotto; Giulia Cesaroni; Luigi Bisanti; Francesco Forastiere; Roberta Onorati; Barbara Pacelli; Paolo Pandolfi; Antonio Russo; Teresa Spadea; Carlo A Perucci Journal: Int J Qual Health Care Date: 2006-12-11 Impact factor: 2.038
Authors: Sharon L Brennan; Stephen E Lane; Michelle Lorimer; Rachelle Buchbinder; Anita E Wluka; Richard S Page; Richard H Osborne; Julie A Pasco; Kerrie M Sanders; Kara Cashman; Peter R Ebeling; Stephen E Graves Journal: BMC Musculoskelet Disord Date: 2014-10-28 Impact factor: 2.362
Authors: Linnea Oldsberg; Göran Garellick; Ingrid Osika Friberg; Anke Samulowitz; Ola Rolfson; Szilárd Nemes Journal: BMC Health Serv Res Date: 2019-05-30 Impact factor: 2.655
Authors: Hoyune E Cho; Lu Wang; Jung-Sheng Chen; Mochuan Liu; Chang-Fu Kuo; Kevin C Chung Journal: BMC Health Serv Res Date: 2019-12-23 Impact factor: 2.655